Cargando…

Ciprofloxacin-Loaded Zein/Hyaluronic Acid Nanoparticles for Ocular Mucosa Delivery

Bacterial conjunctivitis is a worldwide problem that, if untreated, can lead to severe complications, such as visual impairment and blindness. Topical administration of ciprofloxacin is one of the most common treatments for this infection; however, topical therapeutic delivery to the eye is quite ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacinto, Telma A., Oliveira, Breno, Miguel, Sónia P., Ribeiro, Maximiano P., Coutinho, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332751/
https://www.ncbi.nlm.nih.gov/pubmed/35893813
http://dx.doi.org/10.3390/pharmaceutics14081557
_version_ 1784758725211324416
author Jacinto, Telma A.
Oliveira, Breno
Miguel, Sónia P.
Ribeiro, Maximiano P.
Coutinho, Paula
author_facet Jacinto, Telma A.
Oliveira, Breno
Miguel, Sónia P.
Ribeiro, Maximiano P.
Coutinho, Paula
author_sort Jacinto, Telma A.
collection PubMed
description Bacterial conjunctivitis is a worldwide problem that, if untreated, can lead to severe complications, such as visual impairment and blindness. Topical administration of ciprofloxacin is one of the most common treatments for this infection; however, topical therapeutic delivery to the eye is quite challenging. To tackle this, nanomedicine presents several advantages compared to conventional ophthalmic dosage forms. Herein, the flash nanoprecipitation technique was applied to produce zein and hyaluronic acid nanoparticles loaded with ciprofloxacin (ZeinCPX_HA NPs). ZeinCPX_HA NPs exhibited a hydrodynamic diameter of <200 nm and polydispersity index of <0.3, suitable for ocular drug delivery. In addition, the freeze-drying of the nanoparticles was achieved by using mannitol as a cryoprotectant, allowing their resuspension in water without modifying the physicochemical properties. Moreover, the biocompatibility of nanoparticles was confirmed by in vitro assays. Furthermore, a high encapsulation efficiency was achieved, and a release profile with an initial burst was followed by a prolonged release of ciprofloxacin up to 24 h. Overall, the obtained results suggest ZeinCPX_HA NPs as an alternative to the common topical dosage forms available on the market to treat conjunctivitis.
format Online
Article
Text
id pubmed-9332751
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93327512022-07-29 Ciprofloxacin-Loaded Zein/Hyaluronic Acid Nanoparticles for Ocular Mucosa Delivery Jacinto, Telma A. Oliveira, Breno Miguel, Sónia P. Ribeiro, Maximiano P. Coutinho, Paula Pharmaceutics Article Bacterial conjunctivitis is a worldwide problem that, if untreated, can lead to severe complications, such as visual impairment and blindness. Topical administration of ciprofloxacin is one of the most common treatments for this infection; however, topical therapeutic delivery to the eye is quite challenging. To tackle this, nanomedicine presents several advantages compared to conventional ophthalmic dosage forms. Herein, the flash nanoprecipitation technique was applied to produce zein and hyaluronic acid nanoparticles loaded with ciprofloxacin (ZeinCPX_HA NPs). ZeinCPX_HA NPs exhibited a hydrodynamic diameter of <200 nm and polydispersity index of <0.3, suitable for ocular drug delivery. In addition, the freeze-drying of the nanoparticles was achieved by using mannitol as a cryoprotectant, allowing their resuspension in water without modifying the physicochemical properties. Moreover, the biocompatibility of nanoparticles was confirmed by in vitro assays. Furthermore, a high encapsulation efficiency was achieved, and a release profile with an initial burst was followed by a prolonged release of ciprofloxacin up to 24 h. Overall, the obtained results suggest ZeinCPX_HA NPs as an alternative to the common topical dosage forms available on the market to treat conjunctivitis. MDPI 2022-07-27 /pmc/articles/PMC9332751/ /pubmed/35893813 http://dx.doi.org/10.3390/pharmaceutics14081557 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jacinto, Telma A.
Oliveira, Breno
Miguel, Sónia P.
Ribeiro, Maximiano P.
Coutinho, Paula
Ciprofloxacin-Loaded Zein/Hyaluronic Acid Nanoparticles for Ocular Mucosa Delivery
title Ciprofloxacin-Loaded Zein/Hyaluronic Acid Nanoparticles for Ocular Mucosa Delivery
title_full Ciprofloxacin-Loaded Zein/Hyaluronic Acid Nanoparticles for Ocular Mucosa Delivery
title_fullStr Ciprofloxacin-Loaded Zein/Hyaluronic Acid Nanoparticles for Ocular Mucosa Delivery
title_full_unstemmed Ciprofloxacin-Loaded Zein/Hyaluronic Acid Nanoparticles for Ocular Mucosa Delivery
title_short Ciprofloxacin-Loaded Zein/Hyaluronic Acid Nanoparticles for Ocular Mucosa Delivery
title_sort ciprofloxacin-loaded zein/hyaluronic acid nanoparticles for ocular mucosa delivery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332751/
https://www.ncbi.nlm.nih.gov/pubmed/35893813
http://dx.doi.org/10.3390/pharmaceutics14081557
work_keys_str_mv AT jacintotelmaa ciprofloxacinloadedzeinhyaluronicacidnanoparticlesforocularmucosadelivery
AT oliveirabreno ciprofloxacinloadedzeinhyaluronicacidnanoparticlesforocularmucosadelivery
AT miguelsoniap ciprofloxacinloadedzeinhyaluronicacidnanoparticlesforocularmucosadelivery
AT ribeiromaximianop ciprofloxacinloadedzeinhyaluronicacidnanoparticlesforocularmucosadelivery
AT coutinhopaula ciprofloxacinloadedzeinhyaluronicacidnanoparticlesforocularmucosadelivery